Sentences with phrase «equine cushing»

Pituitary pars intermedia dysfunction, or PPID, has been called «equine Cushing's disease» by horse owners and veterinarians for years.

PRASCEND is the first and only medicine available in the United States that is approved by the FDA for the control of clinical signs associated with pituitary pars intermedia dysfunction (PPID), historically termed «equine Cushing's disease,» in horses.

Pituitary pars intermedia dysfunction (PPID), often referred to as Equine Cushing's Disease, is the most common endocrine disorder in horses, ponies, donkeys and mules.

These include, but are not limited to, diseases of the respiratory tract such as pneumonia, recurrent airway obstruction (RAO or heaves), and exercise induced pulmonary hemorrhage (EIPH); neurological abnormalities such as wobbler's syndrome and equine protozoal myeloencephalitis (EPM); gastrointestinal diseases such as colic, diarrhea, equine gastric ulcer syndrome (EGUS), and weight loss; endocrine conditions such as equine metabolic syndrome (EMS) and Pituitary Pars Intermedia Dysfunction (PPID, or Equine Cushing's syndrome); neonatal foal care; and many more.

Is it nutritional, dental or due to another serious disease such as pituitary pars intermedia dysfunction (equine Cushing's) or cancer?

Not exact matches

The two most common hormonal disorders in horses are Cushing's disease, correctly called PPID, and insulin resistance or insulin dysregulation, which is the same as equine metabolic syndrome.